Soligenix grants director options for 78,947 shares
A Soligenix director received a stock option grant for 78,947 shares at a $0.38 exercise price, vesting in four installments through 2027.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
SOLIGENIX, INC. (SNGX) reported that director Anthony Gregg Lapointe received a grant of stock options covering 78,947 shares of common stock on September 17, 2026. The options have an exercise price of $0.38 per share and expire on September 16, 2036.
The option grant vests ratably on December 17, 2026, March 17, 2027, June 17, 2027, and September 17, 2027. All 78,947 option shares are held directly following this grant, and no Rule 10b5-1 trading plan is reported.
Insider Trade Summary
Grant/Award: 78,947 shares
Grant/Award
1 txn
Insider
LAPOINTE ANTHONY GREGG
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F1 | 78,947 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 78,947 contracts (Direct)
Footnotes (1)
- F1. The stock option vests ratably on each of December 17, 2026, March 17, 2027, June 17, 2027 and September 17, 2027.
Key Figures
Options granted: 78,947 options
Exercise price: $0.38 per share
Underlying common shares: 78,947 shares
+3 more
6 metrics
Options granted
78,947 options
Stock option grant to director on September 17, 2026
Exercise price
$0.38 per share
Conversion or exercise price for the stock options
Underlying common shares
78,947 shares
Common stock underlying the option grant
Options held after transaction
78,947 options
Total derivative securities held directly after the grant
Option expiration date
September 16, 2036
Expiration of the granted options
Vesting dates
4 installments from December 17, 2026 to September 17, 2027
Ratable vesting schedule for the option grant
Key Terms
Stock Option, exercise price, vesting, expiration date
4 terms
Stock Option financial
"The stock option vests ratably on each of December 17, 2026, March 17, 2027"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise price financial
"conversion_or_exercise_price": "0.3800""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The stock option vests ratably on each of December 17, 2026"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date": "2036-09-16""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did SOLIGENIX, INC. (SNGX) report in this Form 4?
The filing reports a stock option grant to director Anthony Gregg Lapointe for 78,947 shares of Soligenix common stock, awarded on September 17, 2026, as equity-based compensation.
What is the exercise price of the options granted to the SNGX director?
The options have an exercise price of $0.38 per share, meaning they allow purchase of Soligenix common stock at $0.38 for each of the 78,947 underlying shares, subject to vesting and before expiration.
How do the Soligenix (SNGX) options granted to the director vest?
The stock option vests ratably in four installments on December 17, 2026, March 17, 2027, June 17, 2027, and September 17, 2027, gradually making the 78,947 underlying shares exercisable over that period.
When do the newly granted SNGX options expire?
The options granted to the director expire on September 16, 2036, providing roughly a 10-year term during which vested portions of the 78,947-share grant can be exercised at $0.38 per share.
How many Soligenix (SNGX) options does the director hold after this grant?
Following this transaction, the director holds 78,947 stock options directly from this grant, each exercisable for one share of Soligenix common stock, subject to the stated vesting schedule.
Was the SNGX director’s option grant under a Rule 10b5-1 trading plan?
No. The filing indicates no Rule 10b5-1 trading plan is reported for this option grant; the document-level 10b5-1 checkbox is not marked as being made under such a plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
